 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - BioXcel Therapeutics Inc. (BTAI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-23 Purchase | 2019-08-26 5:38 pm | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 1,554 | $9.34 | $14,514 | 168,320 (Direct) | View |
| 2019-08-21 Purchase | 2019-08-23 4:26 pm | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 8,446 | $8.743 | $73,840 | 166,766 (Direct) | View |
| 2019-08-16 Purchase | 2019-08-19 4:16 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 974 | $8.89 | $8,659 | 9,957 (Direct) | View |
| 2019-08-14 Purchase | 2019-08-16 4:17 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 2,983 | $8.642 | $25,780 | 8,983 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-14 4:15 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 1,000 | $8.75 | $8,750 | 6,000 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-14 4:15 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 6,547 | $8.67 | $56,762 | 8,397 (Direct) | View |
| 2018-12-14 Purchase | 2018-12-14 4:30 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 2,000 | $4.383 | $8,766 | 5,000 (Direct) | View |
| 2018-12-06 Purchase | 2018-12-07 5:50 pm | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 8,795 | $5.008 | $44,045 | 158,320 (Direct) | View |
| 2018-12-04 Purchase | 2018-12-06 5:34 pm | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 4,007 | $5.127 | $20,544 | 149,525 (Direct) | View |
| 2018-12-03 Purchase | 2018-12-06 06:04 am | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 900 | $5.214 | $4,692 | 1,850 (Direct) | View |
| 2018-12-04 Purchase | 2018-12-04 5:05 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 1,000 | $5.12 | $5,120 | 3,000 (Direct) | View |
| 2018-12-03 Purchase | 2018-12-04 10:22 am | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 1,000 | $5.165 | $5,165 | 2,000 (Direct) | View |
| 2018-12-03 Purchase | 2018-12-04 09:49 am | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I CFO | 500 | $5.2 | $2,600 | 1,500 (Direct) | View |
| 2018-11-30 Purchase | 2018-11-30 5:36 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I CFO | 500 | $5 | $2,500 | 1,000 (Direct) | View |
| 2018-11-30 Purchase | 2018-11-30 5:35 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 450 | $5.199 | $2,340 | 950 (Direct) | View |
| 2018-11-29 Purchase | 2018-11-30 4:17 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 1,000 | $4.915 | $4,915 | 1,000 (Direct) | View |
| 2018-11-30 Purchase | 2018-11-30 4:10 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 1,000 | $5.104 | $5,104 | 1,000 (Direct) | View |
| 2018-11-29 Purchase | 2018-11-30 2:31 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 500 | $5.022 | $2,511 | 500 (Direct) | View |
| 2018-11-29 Purchase | 2018-11-30 2:30 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I CFO | 500 | $5 | $2,500 | 500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-14 Exercise | 2020-02-19 5:22 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 80,000 | $0.41 | 69,310 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-19 5:22 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 80,000 | $0.41 | 69,310 (Direct) | View |
| 2018-07-02 Gift | 2020-02-14 4:25 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2018-07-02 Gift | 2020-02-14 4:25 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 90,000 | $0 | 90,000 (Indirect) | View |
| 2019-05-23 Option Award | 2019-06-19 9:07 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 4,700 | $10.04 | 0 (Direct) | View |
| 2019-05-23 Other | 2019-06-19 9:07 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 4,700 | $10.04 | 0 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 9:01 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director | 14,700 | $10.04 | 14,700 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 9:00 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 14,700 | $10.04 | 14,700 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 8:59 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO | 187,700 | $10.04 | 187,700 (Direct) | View |
| 2019-03-07 Disposition | 2019-03-18 5:38 pm | N/A 2029-03-07 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 10,000 | $7.91 | 0 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-13 5:13 pm | N/A 2028-03-12 | BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director | 37,209 | $11 | 124,188 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-13 5:12 pm | N/A 2028-03-12 | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I CFO | 32,232 | $11 | 116,130 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-13 5:12 pm | N/A 2028-03-12 | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 37,209 | $11 | 161,397 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-13 5:11 pm | N/A 2028-03-12 | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 36,498 | $11 | 185,808 (Direct) | View |
| 2018-03-12 Option Award | 2018-03-13 5:10 pm | N/A 2028-03-12 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 31,047 | $11 | 155,472 (Direct) | View |